| HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire a Premier West Coast Interventional Psychiatric Clinic | 10/03 06:55 | prnewswire.com |
| NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announces Completion of Twelve Months of Stability on the First Manufactured Commercial Scale Lot of NRX-100 (Ketamine) | 09/30 07:00 | prnewswire.com |
| NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com | 09/11 07:55 | prnewswire.com |
| NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) and HOPE Therapeutics, Inc. Announce Participation at the H.C. Wainwright 26th Annual Global Investment Conference September 9-11, 2024 | 09/03 07:55 | prnewswire.com |
| HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Potential Acquisition and Financing Agreements for $30 Million in Currently-Operating Interventional Psychiatry Clinics | 08/26 07:55 | prnewswire.com |
| NRx Pharmaceuticals, Inc. (NRXP) Q2 2024 Earnings Call Transcript | 08/15 14:39 | seekingalpha.com |
| NRx Pharmaceuticals (NASDAQ:NRXP) Reports Second Quarter and Year to Date 2024 Financial Results and Provides Business Update | 08/14 16:01 | prnewswire.com |
| NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Second Quarter and Year to Date 2024 Financial Results on August 14, 2024 | 08/13 16:01 | prnewswire.com |
| NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Up to $16 Million Senior Secured Debt Financing from Anson Funds | 08/13 07:30 | prnewswire.com |
| HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Alignment with FDA on Pediatric Study Plan for NRX-100 (ketamine) | 07/29 08:35 | prnewswire.com |